These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 31354944)
1. Investigating colistin drug resistance: The role of high-throughput sequencing and bioinformatics. Aruhomukama D; Sserwadda I; Mboowa G F1000Res; 2019; 8():150. PubMed ID: 31354944 [TBL] [Abstract][Full Text] [Related]
2. Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria. Mousavi SM; Babakhani S; Moradi L; Karami S; Shahbandeh M; Mirshekar M; Mohebi S; Moghadam MT Curr Microbiol; 2021 Dec; 78(12):4023-4036. PubMed ID: 34633487 [TBL] [Abstract][Full Text] [Related]
3. Virulence Determinants and Plasmid-Mediated Colistin Resistance Tartor YH; Gharieb RMA; Abd El-Aziz NK; El Damaty HM; Enany S; Khalifa E; Attia ASA; Abdellatif SS; Ramadan H Front Cell Infect Microbiol; 2021; 11():761417. PubMed ID: 34888259 [TBL] [Abstract][Full Text] [Related]
4. How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals? Al-Tawfiq JA; Laxminarayan R; Mendelson M Int J Infect Dis; 2017 Jan; 54():77-84. PubMed ID: 27915108 [TBL] [Abstract][Full Text] [Related]
5. Colistin resistance mechanisms in Gram-negative bacteria: a Focus on Escherichia coli. Abavisani M; Bostanghadiri N; Ghahramanpour H; Kodori M; Akrami F; Fathizadeh H; Hashemi A; Rastegari-Pouyani M Lett Appl Microbiol; 2023 Feb; 76(2):. PubMed ID: 36754367 [TBL] [Abstract][Full Text] [Related]
6. Elucidation of molecular mechanism for colistin resistance among Gram-negative isolates from tertiary care hospitals. Urooj M; Ullah R; Ali S; Mohyuddin A; Mirza HM; Faryal R J Infect Chemother; 2022 May; 28(5):602-609. PubMed ID: 35058128 [TBL] [Abstract][Full Text] [Related]
7. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli. Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988 [TBL] [Abstract][Full Text] [Related]
8. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415 [TBL] [Abstract][Full Text] [Related]
14. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates. Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C mBio; 2019 Jul; 10(4):. PubMed ID: 31311879 [TBL] [Abstract][Full Text] [Related]
15. A naturally inspired antibiotic to target multidrug-resistant pathogens. Wang Z; Koirala B; Hernandez Y; Zimmerman M; Park S; Perlin DS; Brady SF Nature; 2022 Jan; 601(7894):606-611. PubMed ID: 34987225 [TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration. Papadopoulos A; Ribera A; Mavrogenis AF; Rodriguez-Pardo D; Bonnet E; Salles MJ; Dolores Del Toro M; Nguyen S; Blanco-García A; Skaliczki G; Soriano A; Benito N; Petersdorf S; Pasticci MB; Tattevin P; Tufan ZK; Chan M; O'Connell N; Pantazis N; Kyprianou A; Pigrau C; Megaloikonomos PD; Senneville E; Ariza J; Papagelopoulos PJ; Giannitsioti E; Int J Antimicrob Agents; 2019 Mar; 53(3):294-301. PubMed ID: 30395988 [TBL] [Abstract][Full Text] [Related]
17. Tridecaptin M, a New Variant Discovered in Mud Bacterium, Shows Activity against Colistin- and Extremely Drug-Resistant Jangra M; Kaur M; Tambat R; Rana R; Maurya SK; Khatri N; Ghafur A; Nandanwar H Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936101 [TBL] [Abstract][Full Text] [Related]
18. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy? Ardebili A; Izanloo A; Rastegar M Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511 [TBL] [Abstract][Full Text] [Related]
19. Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria. Peyclit L; Baron SA; Rolain JM Front Cell Infect Microbiol; 2019; 9():193. PubMed ID: 31245302 [TBL] [Abstract][Full Text] [Related]